This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Umberto Romeo
R&D Manager at Corden Pharma Caponago


Umberto Romeo has more than 10 years of experience in drug product process design, development and manufacturing of chemical and biological compounds throughout all stages of development up to commercialization. He is currently the Head of R&D at CordenPharma Caponago with main responsibilities for lead formulation, analytical development, validation and industrialization activities of injectable drug products. Prior to his current role, he worked as Project and Alliance Manager in Evotec managing complex projects (from Discovery to Phase 3) to successful completion, covering all phases of the project management process (initiation, planning, execution, monitoring and control, and closure) while leading project teams to deliver results within the constraints of schedule. In addition, he worked in UCB as Drug Product Process Design and Development Principal Scientist, where he was responsible for the CMC development activities of Biopharmaceuticals, with a focus on Drug Product Process Design, Development and Technology Transfer to the GMP manufacturing sites. During his position, he established the Drug Product Process Design and Development department, leading a team of 6 people and supporting the CMC development program of the whole UCB biological pipeline. He worked also at Patheon Inc. as Technology Transfer-Project Manager, where he successfully managed the technology transfer of more than 15 drug product manufacturing processes of oral, injectable lyophilized and liquid drug products for European, US, Japanese and ROW markets at Phase 3 /commercial scale into the Monza manufacturing plant. Umberto graduated with a degree in Pharmaceutical Biotechnologies from Milano State University in Italy.

Agenda Sessions

  • LNP-mRNA Manufacturing Technologies – Pilot Study Through a Microfluidic Approach - Room 103